2023-09-28 14:39:22
Futurapolis Health, an event Pointoffers you a reading of the major challenges and issues of today in terms of health, prevention and innovations while reporting on the major upheavals in science.
My health, my battle: Medical progress, environment, well-being, health policy, bioethics, food, and research: it’s regarding all this and much more at the heart of the Opéra Comédie de Montpellier*.
Le Point-Futurapolis health – All rights reserved Futurapolis Santé Maxime Huriez
►►► Some conferences :
► Friday October 13
Water: beware of pollution by medicines
Too many substances end up in water and risk harming health. This is particularly the case for drugs and their metabolites, which can have different effects on our body. Particular attention must be paid to antibiotics and therefore to the risk of antibiotic resistance. More and more research is being carried out to study all the substances to which humans and animals are exposed (specialists speak of an exposome). Including during the reuse – for professional use – of treated wastewater.
With :
Hélène Fenet, Professor of Public Health and Environment, – Montpellier University – Faculty of Pharmaceutical and Biological Sciences Nicolas RocheAMU Interdisciplinarity Mission Manager on the SDGs – High Council for Public Health (HCSP) – Vice-President of the Scientific and Technical Council of the Mediterranean Water Institute (IME) Eric Saves director of the UNESCO International Water Center ICIREWARD in Montpellier
Cancer: ever more precise and effective weapons
Malignant tumors are attacked on all possible fronts, with indisputable results. Surgery is becoming more and more precise, radiotherapy is perfectly focused and chemotherapy – and therefore drug treatments – is constantly progressing. In addition to immunotherapy, which has now largely proven its effectiveness, new treatments – sometimes extremely personalized – regularly enrich the therapeutic arsenal.
With
David Azriaprofessor of radiotherapy, director of SIRIC (integrated cancer research site) in Montpellier and president of the French Society of Oncological Radiotherapy Auriane Cano-Chancelvice-president oncology and hematology at AstraZeneca France Françoise Rimaneixplastic surgeon and senologist, medical director of Gustave Roussy (Villejuif) Delphine Topartteam leader of the Medical Oncology Department of the University Hospital (Montpellier) Marc Ychou, professor of digestive oncology and general director of the Montpellier Cancer Institute
Longevity: the latest discoveries of famous researcher Miroslav Radman
The work of this Franco-Croatian biologist, creator and director of MedILS (Mediterranean Institute of Life Sciences in Split), is the source of immense hope in the fight once morest the harmful effects of advancing age. Throughout his life, he studied DNA repair mechanisms and the aging process. He attributes the latter to the oxidation of proteins which causes irreversible damage such as the change of their conformation and their aggregation, mutations in the DNA and finally cell death. His discoveries are already having practical repercussions in the field of cosmetology.
From 5:45 p.m., dialogue with:
Simon Galasprofessor of molecular genetics of Aging – University of Montpellier – IBMM CNRS Jean-Marc LemaitreInserm research director, co-director of the Institute of Regenerative Medicine and Biotherapies (Inserm / CHU / University of Montpellier) Le Point-Futurapolis sante – All rights reserved Futurapolis Santé Maxime Huriez
► Saturday October 14
Behind the scenes of repairing top athletes
EuroMov is a center for research, innovation and technological development in the sciences of life, health, movement, information and cognition. We study sensorimotor markers – physiological, cognitive, neuromuscular, cerebral, etc. – health, which can enable the early detection of risky behaviors and the prediction of perceptual-motor deficits/gains (talents, expertise, learning, skill). They help to improve the movement and accelerate the rehabilitation of athletes.
With :
Stéphane Perrey, university professor in neurophysiology, director of the European Center for Research on Human Movement (EuroMov) Eva Serrano, expert advisor on high performance at the National Sports Agency, world and European medalist in rhythmic gymnastics
Alzheimer’s, schizophrenia: in pursuit of blood biomarkers
Analyzing blood content to try to understand what is happening in the brain is what the search for multiple biomarkers allows. In psychiatry, their study is intended to dismember diseases (identify their different forms), predict the response to treatments and lead to precision medicine. In neurology, blood biomarkers will make the diagnosis and early detection of Alzheimer’s disease and related diseases more reliable and efficient. The consequences of head trauma will also be better evaluated.
With :
Marion Leboyer, head of the psychiatry and addictology center at the Henri Mondor University Hospitals, director of the genetic psychiatry laboratory at the Mondor Institute of Biomedical Research (Inserm / University of Paris Est Créteil) and of the FondaMental Foundation, Inserm Grand Prix 2021 Sylvain Lehmann, head of the biochemistry and clinical proteomics laboratory at Montpellier University Hospital and director of the Montpellier Neuroscience Institute (Inserm / University of Montpellier).
Autoimmune diseases: when the body attacks itself
While it is intended to protect us once morest viruses, bacteria and other microbes, our immune system can become dysregulated, run amok and attack our own organs. There are at least 80 so-called autoimmune diseases, including type 1 diabetes, multiple sclerosis, rheumatoid arthritis and Crohn’s disease. Researchers are developing new therapeutic strategies once morest these complex pathologies, to control the immune system without risking it letting down its guard once morest infectious agents. Meeting with specialists from the new university hospital institute in Montpellier, Immun4Cure.
With :
Christian Jorgensendirector of the Institute of Regenerative Medicine and Biotherapies of Montpellier (Inserm / CHU / University of Montpellier Farida Djouad, Inserm research director and team leader at the Montpellier Institute of Regenerative Medicine and Biotherapies (Inserm / CHU / University of Montpellier). A patient suffering from rheumatoid arthritis
All the programming HERE !
*Opéra Comédie Montpellier, 11 Bd Victor Hugo, 34000 Montpellier
1695912781
#Futurapolis #Santé #Montpellier #October
